Investment Rating - The report assigns a rating of "Accumulate" for the company [5]. Core Insights - The company is a leader in the IP licensing and commercialization platform in China, with a strong presence in the concert ticketing service sector, continuously expanding the "Damai" brand influence [2][9]. - The IP derivative business is expected to be the primary growth driver, with significant revenue growth projected in the coming years [9]. - The company aims to accelerate its global strategic layout while leveraging its diverse IP matrix across various genres [9]. Financial Summary - Total revenue is projected to grow from 50.4 billion RMB in 2024 to 109.84 billion RMB by 2028, with a CAGR of 19.2% [3][12]. - Net profit is expected to increase from 285 million RMB in 2024 to 1.59 billion RMB in 2028, reflecting a substantial growth trajectory [3][12]. - The company anticipates an EPS of 0.03, 0.04, and 0.05 RMB for the fiscal years 2026, 2027, and 2028 respectively [9][12]. Revenue Breakdown - The IP derivative business is projected to generate 14.33 billion RMB in revenue for the fiscal year 2025, marking a 73% year-on-year increase [9][12]. - The concert ticketing segment, after the full acquisition of Damai, is expected to achieve revenues of 20.57 billion RMB in 2025, a 236% increase [9][12]. - The film segment is projected to see a decline in revenue, with a forecast of 2.71 billion RMB in 2025, down 9.6% year-on-year [12]. Valuation and Price Target - The target price for the company is set at 1.94 HKD based on an average of PE and PS valuation methods for the fiscal year 2026 [9][13]. - The report references comparable companies with an average PE of 50 times for 2025, indicating a favorable valuation outlook for the company [13][14].